Assembly Biosciences
(NASDAQ) ASMB
Assembly Biosciences Financials at a Glance
Market Cap
$491.56M
Revenue (TTM)
$62.88M
Net Income (TTM)
$6.38M
EPS (TTM)
$-1.84
P/E Ratio
-16.82
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Price
$30.37
Volume
100,991.92
Open
$30.54
Price
$30.37
Volume
100,991.92
Open
$30.54
Previous Close
$30.93
Daily Range
$29.16 - $31.50
52-Week Range
$11.64 - $39.70
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Price
$30.37
Volume
100,991.92
Open
$30.54
Previous Close
$30.93
Daily Range
$29.16 - $31.50
52-Week Range
$11.64 - $39.70
ASMB News
ASMB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Assembly Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
73
CEO
Jason A. Okazaki
Website
www.assemblybio.comHeadquarters
South San Francisco, CA 94080, US
ASMB Financials
Key Financial Metrics (TTM)
Gross Margin
74%
Operating Margin
-22%
Net Income Margin
-10%
Return on Equity
-5%
Return on Capital
-7%
Return on Assets
-3%
Earnings Yield
-5.95%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$491.56M
Shares Outstanding
15.89M
Volume
100.99K
Avg. Volume
106.80K
Financials (TTM)
Gross Profit
$72.17M
Operating Income
$12.12M
EBITDA
$11.99M
Operating Cash Flow
$41.09M
Capital Expenditure
$66.00K
Free Cash Flow
$41.16M
Cash & ST Invst.
$248.11M
Total Debt
$2.63M
Assembly Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$0.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
$491.56M
N/A
Market Cap/Employee
$6.73M
N/A
Employees
73
N/A
Net Income
$9.08M
-3.0%
EBITDA
$11.37M
-14.8%
Quarterly Fundamentals
Net Cash
$224.11M
+154.6%
Accounts Receivable
$451.00K
N/A
Inventory
$0.00
N/A
Long Term Debt
$1.90M
-23.7%
Short Term Debt
$590.00K
+11.5%
Return on Assets
-2.71%
N/A
Return on Invested Capital
-6.76%
N/A
Free Cash Flow
$22.12M
+5.6%
Operating Cash Flow
$22.10M
+5.7%